Product Overview
Tesamorelin is a synthetic growth hormone–releasing hormone (GHRH) analogue used as a laboratory tool compound to investigate growth hormone–releasing hormone receptor (GHRHR) signaling and downstream endocrine pathway dynamics in preclinical experimental systems. The molecule incorporates an additional trans-3-hexanoic acid group, a peptide-chemistry modification often used to modulate physicochemical stability and proteolytic susceptibility in biological matrices.
In RUO settings, tesamorelin is applied in mechanistic studies of receptor-coupled signaling, endocrine feedback circuitry, and GH/IGF-axis–associated molecular readouts in controlled in-vitro assays and in-vivo animal models.
Storage & Handling
Molecular Information
Quality Assurance
Every batch undergoes comprehensive third-party testing
HPLC Analysis
High-Performance Liquid Chromatography confirms peptide purity and identity
Mass Spectrometry
Molecular weight verification through advanced mass spec analysis
Endotoxin Testing
LAL assay confirms endotoxin levels meet strict specifications